162 related articles for article (PubMed ID: 6234272)
1. The antimicrobial spectrum of norfloxacin.
Newsom SW
J Antimicrob Chemother; 1984 May; 13 Suppl B():25-31. PubMed ID: 6234272
[TBL] [Abstract][Full Text] [Related]
2. Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
Vogel R; Deaney NB; Round EM; VandenBurg MJ; Currie WJ
J Antimicrob Chemother; 1984 May; 13 Suppl B():113-20. PubMed ID: 6234271
[TBL] [Abstract][Full Text] [Related]
3. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Haase DA; Harding GK; Thomson MJ; Kennedy JK; Urias BA; Ronald AR
Antimicrob Agents Chemother; 1984 Oct; 26(4):481-4. PubMed ID: 6240223
[TBL] [Abstract][Full Text] [Related]
4. Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
Watt B; Chait I; Kelsey MC; Newsom SW; Newsom RA; Smith J; Toase PD; Deaney NB; Round EM; Vogel R
J Antimicrob Chemother; 1984 May; 13 Suppl B():89-94. PubMed ID: 6234281
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
Guerra JG; Falconi E; Palomino JC; Benavente L; Antunez de Mayolo E
Eur J Clin Microbiol; 1983 Jun; 2(3):260-5. PubMed ID: 6224684
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
Schaeffer AJ; Sisney GA
J Urol; 1985 Apr; 133(4):628-30. PubMed ID: 3157008
[TBL] [Abstract][Full Text] [Related]
7. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
Sabbaj J; Hoagland VL; Shih WJ
Antimicrob Agents Chemother; 1985 Mar; 27(3):297-301. PubMed ID: 3158272
[TBL] [Abstract][Full Text] [Related]
8. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
Goldstein EJ; Alpert ML; Ginsberg BP
Antimicrob Agents Chemother; 1985 Mar; 27(3):422-3. PubMed ID: 3158277
[TBL] [Abstract][Full Text] [Related]
9. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
[TBL] [Abstract][Full Text] [Related]
10. Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
Giamarellou H; Tsagarakis J; Petrikkos G; Daikos GK
Eur J Clin Microbiol; 1983 Jun; 2(3):266-9. PubMed ID: 6224685
[TBL] [Abstract][Full Text] [Related]
11. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Cahen P; Honderlick P
Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
[TBL] [Abstract][Full Text] [Related]
12. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
Sweet RL; Ohm-Smith MJ; Hadley WK
J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
[No Abstract] [Full Text] [Related]
13. A review of urinary tract infection in the elderly.
Bendall MJ
J Antimicrob Chemother; 1984 May; 13 Suppl B():69-78. PubMed ID: 6234278
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
Esko E; Renkonen OV
Scand J Infect Dis; 1985; 17(1):95-8. PubMed ID: 3158071
[TBL] [Abstract][Full Text] [Related]
15. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Bauernfeind A; Petermüller C
Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
Khan MY; Gruninger RP; Nelson SM; Klicker RE
Antimicrob Agents Chemother; 1982 May; 21(5):848-51. PubMed ID: 6213200
[TBL] [Abstract][Full Text] [Related]
18. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
Leigh DA; Smith EC; Marriner J
J Antimicrob Chemother; 1984 May; 13 Suppl B():79-83. PubMed ID: 6234279
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
20. Acute cystitis in young women. Treatment with citrated nalidixic acid compared with co-trimoxazole.
Butler AV; Cullen MJ; Parry MO; Sylvester DG; Speller DC
Practitioner; 1983 May; 227(1379):833-5. PubMed ID: 6604266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
